Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Adam D DeVoreAdrian F Hernandez

Abstract

Use of durable, continuous-flow left ventricular assist devices (LVADs) has expanded rapidly, although data are limited regarding optimization strategies before LVAD implantation. We examined current use of intra-aortic balloon pumps (IABPs) before LVAD implantation and compared outcomes of patients with IABP use to those without. We analyzed data from the Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS) on patients who underwent LVAD implantation between 2006 and 2014. We limited the analysis to patients with an admitting diagnosis of LVAD placement. The primary exposure was IABP use within 48 hours before LVAD implantation. We used propensity scores to compare 30 day postoperative outcomes to reduce treatment selection bias. Of 2,446 patients, 433 (18%) received an IABP before LVAD placement. Patients with IABP use, compared with those without, had markers of more advanced disease, including worse renal and liver function, worse right ventricular function, and use of mechanical ventilation (p < 0.05 for all comparisons). A composite outcome of post-operative right heart failure, hepatic dysfunction, renal dysfunction, or death occurred in 83 (19.2%) patients with IABP use, compared with 342 (17.1%)...Continue Reading

References

Nov 28, 2000·The Annals of Thoracic Surgery·O E ArafaJ L Svennevig
Apr 26, 2006·The American Journal of Cardiology·Jeffrey C Trost, L David Hillis
Sep 1, 2007·The New England Journal of Medicine·Leslie W MillerUNKNOWN HeartMate II Clinical Investigators
Nov 19, 2009·The New England Journal of Medicine·Mark S SlaughterUNKNOWN HeartMate II Investigators
Feb 6, 2010·The Journal of Thoracic and Cardiovascular Surgery·Robert L KormosUNKNOWN HeartMate II Clinical Investigators
Aug 28, 2012·The New England Journal of Medicine·Holger ThieleUNKNOWN IABP-SHOCK II Trial Investigators
Jan 29, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David FeldmanUNKNOWN International Society for Heart and Lung Transplantation
Sep 10, 2013·Lancet·Holger ThieleUNKNOWN Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators
Oct 1, 2013·Current Opinion in Cardiology·Sumeet SharmaDivaka Perera
Jan 9, 2014·Current Treatment Options in Cardiovascular Medicine·Adam D DevoreChetan B Patel
Feb 4, 2014·Journal of the American College of Cardiology·Prateeti KhazanieAdrian F Hernandez
May 27, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young
Mar 31, 2015·JAMA Internal Medicine·Yousif AhmadDarrel P Francis
Nov 2, 2015·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young
Jan 7, 2016·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Anthony W CastleberryChetan B Patel

❮ Previous
Next ❯

Citations

Dec 24, 2019·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jaime A Hernandez-MontfortJennifer Cowger
Mar 27, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Bradley TernusJacob Jentzer
Jul 27, 2021·Journal of the American Heart Association·Matthew A BrownEzequiel J Molina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.